Impacts of β-1, 3-N-acetylglucosaminyltransferases (B3GNTs) in human diseases
Abstract Glycosylation modification of proteins is a common post-translational modification that exists in various organisms and has rich biological functions. It is usually catalyzed by multiple glycosyltransferases located in the Golgi apparatus. β-1,3-N-acetylglucosaminyltransferases (B3GNTs) are members of the glycosyltransferases and have been found to be involved in the occurrence and development of a variety of diseases including autoimmunity diseases, cancers, neurodevelopment, musculoskeletal system, and metabolic diseases. The functions of B3GNTs represent the glycosylation of proteins is a crucial and frequently life-threatening step in progression of most diseases. In this review, we give an overview about the roles of B3GNTs in tumor, nervous system, musculoskeletal and metabolic diseases, describing the recent results about B3GNTs, in order to provide a research direction and exploration value for the prevention, diagnosis and treatment of these diseases..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Molecular biology reports - 51(2024), 1 vom: 29. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xie, Anna [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
β-1, 3-N-acetylglucosaminyltransferases |
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s11033-024-09405-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055348211 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055348211 | ||
| 003 | DE-627 | ||
| 005 | 20240330064632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240330s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11033-024-09405-9 |2 doi | |
| 035 | |a (DE-627)SPR055348211 | ||
| 035 | |a (SPR)s11033-024-09405-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a 42.13 |2 bkl | ||
| 100 | 1 | |a Xie, Anna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impacts of β-1, 3-N-acetylglucosaminyltransferases (B3GNTs) in human diseases |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Glycosylation modification of proteins is a common post-translational modification that exists in various organisms and has rich biological functions. It is usually catalyzed by multiple glycosyltransferases located in the Golgi apparatus. β-1,3-N-acetylglucosaminyltransferases (B3GNTs) are members of the glycosyltransferases and have been found to be involved in the occurrence and development of a variety of diseases including autoimmunity diseases, cancers, neurodevelopment, musculoskeletal system, and metabolic diseases. The functions of B3GNTs represent the glycosylation of proteins is a crucial and frequently life-threatening step in progression of most diseases. In this review, we give an overview about the roles of B3GNTs in tumor, nervous system, musculoskeletal and metabolic diseases, describing the recent results about B3GNTs, in order to provide a research direction and exploration value for the prevention, diagnosis and treatment of these diseases. | ||
| 650 | 4 | |a Glycosylation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a β-1, 3-N-acetylglucosaminyltransferases |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cancers |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Neurodevelopment |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Musculoskeletal system |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Metabolic diseases |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Wang, Jingjing |4 aut | |
| 700 | 1 | |a Liu, Yi |4 aut | |
| 700 | 1 | |a Li, Guoqing |4 aut | |
| 700 | 1 | |a Yang, Nanyang |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular biology reports |d Springer Netherlands, 1973 |g 51(2024), 1 vom: 29. März |w (DE-627)SPR015864855 |w (DE-600)1478217-0 |x 1573-4978 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2024 |g number:1 |g day:29 |g month:03 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11033-024-09405-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 42.13 |q VZ |
| 951 | |a AR | ||
| 952 | |d 51 |j 2024 |e 1 |b 29 |c 03 | ||